lunes, 22 de octubre de 2012

Peripheral blood gene expression as a novel genomic... [PLoS One. 2012] - PubMed - NCBI

Peripheral blood gene expression as a novel genomic... [PLoS One. 2012] - PubMed - NCBI

PLoS One. 2012;7(9):e44818. Epub 2012 Sep 12.

Peripheral blood gene expression as a novel genomic biomarker in complicated sarcoidosis.

Source

Institute for Personalized Respiratory Medicine, The University of Illinois at Chicago, Chicago, Illinois, United States of America ; Section of Pulmonary, Critical Care, Sleep and Allergy, Department of Medicine, The University of Illinois at Chicago, Chicago, Illinois, United States of America.

Abstract

Sarcoidosis, a systemic granulomatous syndrome invariably affecting the lung, typically spontaneously remits but in ∼20% of cases progresses with severe lung dysfunction or cardiac and neurologic involvement (complicated sarcoidosis). Unfortunately, current biomarkers fail to distinguish patients with remitting (uncomplicated) sarcoidosis from other fibrotic lung disorders, and fail to identify individuals at risk for complicated sarcoidosis. We utilized genome-wide peripheral blood gene expression analysis to identify a 20-gene sarcoidosis biomarker signature distinguishing sarcoidosis (n = 39) from healthy controls (n = 35, 86% classification accuracy) and which served as a molecular signature for complicated sarcoidosis (n = 17). As aberrancies in T cell receptor (TCR) signaling, JAK-STAT (JS) signaling, and cytokine-cytokine receptor (CCR) signaling are implicated in sarcoidosis pathogenesis, a 31-gene signature comprised of T cell signaling pathway genes associated with sarcoidosis (TCR/JS/CCR) was compared to the unbiased 20-gene biomarker signature but proved inferior in prediction accuracy in distinguishing complicated from uncomplicated sarcoidosis. Additional validation strategies included significant association of single nucleotide polymorphisms (SNPs) in signature genes with sarcoidosis susceptibility and severity (unbiased signature genes - CX3CR1, FKBP1A, NOG, RBM12B, SENS3, TSHZ2; T cell/JAK-STAT pathway genes such as AKT3, CBLB, DLG1, IFNG, IL2RA, IL7R, ITK, JUN, MALT1, NFATC2, PLCG1, SPRED1). In summary, this validated peripheral blood molecular gene signature appears to be a valuable biomarker in identifying cases with sarcoidoisis and predicting risk for complicated sarcoidosis.

PMID:
22984568
[PubMed - in process]
PMCID:
PMC3440319
Free PMC Article

1 comentario:

  1. Hi, probably our entry may be off topic but anyways, I have been surfing around your blog and it looks very professional. It’s obvious you know your topic and you appear fervent about it. I’m developing a fresh blog plus I’m struggling to make it look good, as well as offer the best quality content. I have learned much at your web site and also I anticipate alot more articles and will be coming back soon. Thanks you.

    Luzes LED Tube

    ResponderEliminar